Literature DB >> 11684851

Familial and sporadic renal oncocytomas--a comparative molecular-genetic analysis.

K Junker1, G Weirich, P Moravek, M Podhola, B Ilse, A Hartmann, J Schubert.   

Abstract

OBJECTIVES: Genetic causes of sporadic and familial renal oncocytomas are not known. We analyzed these tumors genetically in order to detect tumor-specific chromosome alterations.
METHODS: DNA from 26 sporadic and 31 familial renal oncocytomas were screened by comparative genomic hybridization according to standard protocols including degenerate oligonucleotide-primed PCR.
RESULTS: Chromosome alterations were detected in 19/26 sporadic (73%) and in 4/31 familial renal oncocytomas (13%). Partial or complete losses of chromosome 1 were most frequently found in both sporadic (15/26) and familial tumors (2/4). Less frequently, loss of chromosome 14 (3/26) was detected in sporadic renal oncocytomas as well as losses of 2p, 2q, 4q, 10 and 18 and gains of 1q and 17q in individual sporadic tumors. Inter-tumor variation of chromosome aberrations was prominent in 1 patient, where 1 tumor showed gains of chromosomes 5, 6q, 7, 10p, 12 and 13q, whereas the second tumor exhibited gains of chromosomes 5 and 7 and loss of 10q. In contrast to sporadic renal oncocytomas, most familial tumors (87%) were devoid of chromosome instabilities.
CONCLUSION: Our results demonstrate that partial or complete loss of chromosome 1 is the most common alteration in renal oncocytomas, sporadic and familial. However, chromosome changes are much rarer in familial than in sporadic renal oncocytomas.

Entities:  

Mesh:

Year:  2001        PMID: 11684851     DOI: 10.1159/000049795

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  8 in total

1.  The impact of germline BHD mutation on histological concordance and clinical treatment of patients with bilateral renal masses and known unilateral oncocytoma.

Authors:  Ronald S Boris; Jihane Benhammou; Maria Merino; Peter A Pinto; W Marston Linehan; Gennady Bratslavsky
Journal:  J Urol       Date:  2011-04-15       Impact factor: 7.450

2.  Case report of a symptomatic giant renal oncocytoma.

Authors:  Sarfraz Ahmad; Rustom Manecksha; Brian D Hayes; Ronald Grainger
Journal:  Int J Surg Case Rep       Date:  2011-03-03

3.  Giant asymptomatic left renal oncocytoma in a 40-year-old man: a case report.

Authors:  Sultan Qaid; Radman Ghaleb; Faisal Ahmed; Ebrahim Al-Shami; Qasem Alyhari; Saleh Al-Wageeh; Mohammad Reza Askarpour
Journal:  Pan Afr Med J       Date:  2022-07-05

4.  [Tumor profiling of renal cell tumors: relevance for diagnostics and therapy].

Authors:  K Junker; T Steiner; J Sanjmyatav; R Pilchowski; C Heinze; M Walter; J Schubert
Journal:  Pathologe       Date:  2009-03       Impact factor: 1.011

5.  Bilateral multifocal renal oncocytoma.

Authors:  Abolhassan Seyedzadeh; Karan Parashar; Faro Raafat; Helen M Alton; David V Milford
Journal:  Pediatr Nephrol       Date:  2003-10-24       Impact factor: 3.714

6.  Birt-Hogg-Dubé renal tumors are genetically distinct from other renal neoplasias and are associated with up-regulation of mitochondrial gene expression.

Authors:  Jeff A Klomp; David Petillo; Natalie M Niemi; Karl J Dykema; Jindong Chen; Ximing J Yang; Annika Sääf; Peter Zickert; Markus Aly; Ulf Bergerheim; Magnus Nordenskjöld; Sophie Gad; Sophie Giraud; Yves Denoux; Laurent Yonneau; Arnaud Méjean; Viorel Vasiliu; Stéphane Richard; Jeffrey P MacKeigan; Bin T Teh; Kyle A Furge
Journal:  BMC Med Genomics       Date:  2010-12-16       Impact factor: 3.063

7.  Palpable Abdominal Mass is a Renal Oncocytoma: Not All Large Renal Masses are Malignant.

Authors:  Sumi Dey; Sabrina L Noyes; Ghayas Uddin; Brian R Lane
Journal:  Case Rep Urol       Date:  2019-08-08

8.  Virtual karyotyping with SNP microarrays reduces uncertainty in the diagnosis of renal epithelial tumors.

Authors:  Jill M Hagenkord; Anil V Parwani; Maureen A Lyons-Weiler; Karla Alvarez; Robert Amato; Zoran Gatalica; Jose M Gonzalez-Berjon; Leif Peterson; Rajiv Dhir; Federico A Monzon
Journal:  Diagn Pathol       Date:  2008-11-06       Impact factor: 2.644

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.